VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$19.91
+0.94 (+4.96%)
Performance
1D
+0.00%
1W
+6.64%
1M
+14.16%
3M
+22.30%
6M
+17.67%
1Y
+96.74%
YTD
+59.79%
Open$18.79
Previous Close$18.97
Day High$19.94
Day Low$18.79
52W High$19.96
52W Low$9.92
Volume—
Avg Volume8.16M
Market Cap22.38B
P/E Ratio—
EPS$-0.36
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$17.70
Above
SMA 200
$16.05
Above
RSI (14)
68.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
18 analysts
Price Target
+516.9% upside
Current
$19.91
$19.91
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.73B | 14.33B | 3.47B |
| Net Income | -3,374,543,785 | -3,170,239,463 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | 31.13M | 30.87M | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield5.09%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |